LifeVantage Corporation LFVN 深 滬
等待開盤 01-12 09:30:00 美东时间
6.49
+0.150
+2.37%
華盛通- 最 高6.57
- 今 開6.41
- 成交量 11.39万股
- 最 低 6.295
- 昨 收 6.34
- 總市值 8236.46万
- 52周最高 25.715
- 市盈率 靜 8.60
- 換手率 0.00%
- 52周最低 5.69
- 委 比 20.00%
- 總股本 1269.10万
- 歷史最高 27.205
- 量 比 1.20
- 振 幅 4.34%
- 歷史最低 0.445
- 每 手 1
- 風險率 4.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation
LifeVantage appoints Mike Edwards as Chief Technology Officer, leveraging his 25 years of experience to drive digital transformation and enhance technology solutions. Edwards, known for enterprise-wide technology initiatives, will focus on scaling infrastructure, improving customer experiences, and supporting the company's growth strategy. LifeVantage, a leader in nutrigenomics, offers products designed to activate cellular health and operates a ...
01-07 21:05
LifeVantage to Participate in the 28th Annual ICR Conference
LifeVantage Corporation (LFVN) announced that its CEO, Steve Fife, and CFO, Carl Aure, will present at the 28th Annual ICR Conference in Orlando on January 12, 2026. The presentation will be webcast on the company’s Investor Relations website. LifeVantage, a leader in nutrigenomics, offers products designed to activate health at the cellular level, including Protandim® and other science-backed activators. The company, founded in 2003, is headquar...
01-06 21:05
LifeVantage to Participate in Water Tower Fireside Chat on Thursday, December 11, 2025
LifeVantage Corporation (Nasdaq: LFVN) announced that CEO Steve Fife and CFO Carl Aure will participate in the Water Tower Fireside Chat Series on December 11, 2025. The webcast will begin at 2:00 p.m. Eastern Time and is open to all investors. Interested parties can register through the provided links. LifeVantage, a leader in nutrigenomics, offers products like the Protandim® family of products and TrueScience® Liquid Collagen. Founded in 2003,...
2025-12-10 13:00
LifeVantage Trial Results From New In Vitro Demonstrates All 14 Peptides Influences In Desired Direction
LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new in vitro study results for its
2025-11-12 21:08
Lifevantage Corporation shares are trading higher. The company reported Q1 financial results.
Lifevantage Corporation shares are trading higher. The company reported Q1 fina...
2025-11-05 05:57
LifeVantage Declares Quarterly Dividend
LifeVantage Corporation announced a quarterly cash dividend of $0.045 per share, payable on December 15, 2025, to stockholders of record as of December 1, 2025. The company, headquartered in Utah, specializes in nutrigenomics and offers products designed to optimize health at the cellular level. This dividend declaration does not guarantee future dividends, and forward-looking statements are subject to risks and uncertainties.
2025-11-04 21:06
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
2025-11-04 19:12
LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Academy 2025
<p>LifeVantage Corporation held Momentum Academy 2025 in Dallas, bringing together thousands of Consultants to explore new products, tools, and strategies to boost business performance and leadership. The event, themed "Love Life & Drive," marked the first large-scale collaboration between LifeVantage and LoveBiome Consultants, emphasizing unity and innovation. Guests were introduced to Healthy Edge, combining Protandim® and LoveBiome P84, a new ...
2025-10-28 12:00
LifeVantage to Participate in the LD Micro Main Event XIX on October 20, 2025
Steve Fife, CEO of LifeVantage, will present at LD Micro Main Event XIX on October 20, 2025. Investors can access the live webcast and replay on the company's investor relations website. LifeVantage is a leader in nutrigenomics, offering products designed to activate health at the cellular level, including Protandim, TrueScience, and AXIO. Founded in 2003, the company is headquartered in Lehi, Utah.
2025-10-13 20:05
LifeVantage Announces Closing of LoveBiome Acquisition
LifeVantage Corporation has completed the acquisition of LoveBiome, a direct sales company specializing in microbiome care, enhancing its presence in the gut and microbiome health market. The deal includes key assets and personnel, and aims to expand LifeVantage's product portfolio and reach in the US, Taiwan, and Europe. LifeVantage CEO Steve Fife highlighted the strategic growth opportunity, while LoveBiome CEO Kelly Olsen expressed excitement ...
2025-10-02 12:00
